Pharma Mar SA

General

Total Cases7
Active Cases5
Patents2
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
09/13/24
Proposed Summons. by Jazz Pharmaceuticals Ireland Limited, Pharma Mar, S.A. (Dombrowski, Damien) (Entered: 09/13/2024)
09/13/24
Notice of Report on the filing of an action regarding a Patent. (Attachments: # [1] Complaint, # [2] Exhibit A) (LJ) (Entered: 09/13/2024)
09/13/24
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Jazz Pharmaceuticals plc for Jazz Pharmaceuticals Ireland Limited filed by Jazz Pharmaceuticals Ireland Limited, Pharma Mar, S.A.. (Attachments: # 1 Certificate of Service)(O'Brien, Daniel) (Entered: 09/13/2024)
09/13/24
Clerk's Notice Re: Consent. A United States Magistrate Judge has been assigned to this case and is available to conduct all proceedings. In accordance with Rule 73 of the Federal Rules of Civil Procedure, Local Rule 73.1, the parties are notified that if all parties consent, the assigned Magistrate Judge is available to conduct all proceedings in this action including a (jury or nonjury) trial and to order the entry of a final judgment. Attached to this Notice is a blank copy of the consent form that should be filled out, signed and filed electronically only if all parties wish to consent. Any party may withhold its consent without adverse substantive consequences. Do NOT return or file the consent unless all parties have signed the consent.The form may also be accessed at the following link: [https://img.nyed.uscourts.gov/files/forms/MJConsentForm.pdf] (LJ) (Entered: 09/13/2024)
09/13/24
This attorney case opening filing has been checked for quality control. See the attachment for corrections that were made. (LJ) (Entered: 09/13/2024)
09/13/24
Case Assigned to Judge Joan M. Azrack and Magistrate Judge James M. Wicks. Please download and review the Individual Practices of the assigned Judges, located on our [website]. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. (LJ) (Entered: 09/13/2024)
09/13/24
Your proposed summons was not issued for the following reasons: The full case caption must appear on the summons. Additionally, the summons provided only has the name/address for one defendant. Please include all defendants addresses for a summons to be issued as to each. Please correct and resubmit using the event Proposed Summons/Civil Cover Sheet. (LJ) (Entered: 09/13/2024)
09/13/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,763,615. (mpb) (Entered: 09/13/2024)
09/13/24
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/13/2024. Date of Expiration of Patent: 12/13/2029.Thirty Month Stay Deadline: 12/15/2027. (mpb) (Entered: 09/13/2024)
09/13/24
DEFICIENCY NOTICE issued by the Court to Plaintiff: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (mpb) (Entered: 09/13/2024)